ArticleInternational journal of clinical oncology2021

Prognostic significance of third-line treatment for patients with metastatic castration-resistant prostate cancer: comparative assessments between cabazitaxel and other agents.

Hideaki Miyake et al.PubMed ↗Publisher ↗

No numbers read from the abstract.